The specialist medical diagnostic producer exports approximately 90% of the products manufactured at its Birmingham head office, with total worldwide Group revenues last year exceeding £80m.
The firm were also recently awarded the Queen’s Award for Enterprise in the category of International Trade.
Speaking about the award Charles de Rohan, CEO of Binding Site, said: “I am very proud to be able to announce this award as it recognises not only the combined efforts of all our staff and partners here and overseas, but also demonstrates the very real value of our products that is seen by physicians using them daily around the globe."
For over 30 years Binding Site has specialised in producing highly sensitive and specific antibodies for the detection of certain cancers and other serious disorders which are delivered as in-vitro diagnostic test kits to hospitals and clinical laboratories globally.
Binding Site currently employ over 800 staff, 500 based in the UK, and deliver products in 80 countries.